Besides SLE patients, treatment with glucocorticoids yields increase in Treg cells and FoxP3 levels in patients with asthma [33], immune thrombocytopenia purpura patients [34] and multiple sclerosis [35]. Here, FOXP3 is linked to systemic lupus erythematosus.